About

Our Mission 

To accelerate promising discoveries into medicines for unmet needs. 

Who We Are  

We have a singular mission to create new medicines. We were established to support physician-scientists who strive to change the standard of care in medicine. Our model has expanded to include all scientists with discoveries in unmet medical needs, with a particular focus on brain health, rare diseases, COVID-19 and major diseases affecting society.  

Core Values

At Harrington Discovery Institute, we believe that our culture of innovation matters as much as our mission to accelerate promising discoveries into medicines for unmet needs. We are committed to creating and sustaining a culture that is shaped by these core values:

Impact 

We work in areas that have great influence on human health and improve our world. 

Results 

We're in this to find cures. We set metrics, strive for success and measure ourselves accordingly. 

Innovation 

We are driven to think and act differently. We invent in both ideas and implementation. 

Tenacity 

We persevere through adversity in order to grow and make an impact. 

Passion 

We see true meaning in what we do and why we do it. 

Integrity 

We have it. At all times.

What We Do

Today more than 500 million people worldwide are living with diseases without available treatments. Despite breathtaking advances in basic science, economic and regulatory environments have led to an unacceptable low rate of new therapeutics. 

We have created a model for drug discovery and development that is:

• Distinctive — a blended non-profit/for-profit model to maximize impact
• Focused on Excellence — provides access to the best science in academic institutions
• Competitive – accelerates discoveries rapidly and effectively

How We Do It

We advance discoveries toward clinical trials utilizing our:

• Network of top researchers across the US, Canada, and UK
• Scale including multiple portfolios of drugs to increase success
• Expertise in science, business and drug development

Why Our Model Works

• Well-developed processes
  • Sourcing  
  • Advancing
  • Commercializing 
• Value in strategic partners
  • Funding
  • Expertise
  • Risk-sharing
• Unique investment approach
  • De-risking through philanthropy
  • Market-rate returns
  • Impact measures